Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arobella Medical, a medical device company, has received European CE Mark approval for its Qoustic Wound Therapy System medical device for ultrasound aided wound care. The device is FDA-cleared and is already on sale in the US.
Subscribe to our email newsletter
According to Arobella Medical, the wound therapy system uses a unique, dome-shaped curette tip to apply low-frequency, cavitational ultrasound to wounds.
The combination of physical design and ultrasonic energy gently removes dead and diseased tissue cells, kills harmful bacteria and biofilm, and leaves healthy and pre-healing granulation tissue intact, the company said.
Eliaz Babaev, president and CEO of Arobella Medical, said: “The Qoustic Wound Therapy System device offers cutting-edge ultrasound technology several generations ahead of its competitors. We look forward to bringing this device to the international market. Arobella Medical continually strives to be the best in ultrasound, and we have the data to prove it.”